Biogen CEO search focuses on scientists, with former J&J exec as a leading candidate
Acer Therapeutics Receives Notice of Allowance Of Key U.S. Patent Application Covering ACER-001 Formulation
Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, RELIEF THERAPEUTICS Holding SA ((SIX: RLF, OTCQB:RLFTF) ("Relief"), today announced that the U.S. Patent and Trademark
